Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than ever

키워드

참고문헌 (23)

1. GBD 2017 Cirrhosis Collaborators, "The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017", Lancet Gastroenterol Hepatol, 5, pp.245~266 (2020)
2. Asrani SK, "Burden of liver diseases in the world", J Hepatol, 70, pp.151~171 (2019)
3. Pimpin L, "Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies", J Hepatol, 69, pp.718~735 (2018)
4. Moon AM, "Contemporary epidemiology of chronic liver disease and cirrhosis", Clin Gastroenterol Hepatol, 18, pp.2650~2666 (2020)
5. Carrat F, "Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study", Lancet, 393, pp.1453~1464 (2019)
6. Backus LI, "Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease", Hepatology, 69, pp.487~497 (2019)
7. Ott JJ, "Time trends of chronic HBV infection over prior decades - a global analysis", J Hepatol, 66, pp.48~54 (2017)
8. Goldberg D, "Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation", Gastroenterology, 152, pp.1090~1099.e1 (2017)
9. Bajaj JS, "The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis", Hepatology, 64, pp.200~208 (2016)
10. Priyanka Jain, "Alcohol associated liver cirrhotics have higher mortality after index hospitalization: Long-term data of 5,138 patients", Clinical and Molecular Hepatology, 27(1), pp.175~185 (2021), 대한간학회[DOI]
11. Sarin SK, "Young v adult cirrhotics: a prospective, comparative analysis of the clinical profile, natural course and survival", Gut, 29, pp.101~107 (1988)
12. Julien J, "Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019-40: a modelling study", Lancet Public Health, 5, pp.e316~e323 (2020)
13. European Association for the Study of the Liver, "EASL clinical practice guidelines: management of alcohol-related liver disease", J Hepatol, 69, pp.154~181 (2018)
14. Lackner C, "Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease", J Hepatol, 66, pp.610~618 (2017)
15. Piano S, "Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis", J Hepatol, 67, pp.1177~1184 (2017)
16. Rogal S, "Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis", Hepatology, 71, pp.2080~2092 (2020)
17. Seung Ha Park, "Global and regional impacts of alcohol use on public health: Emphasis on alcohol policies", Clinical and Molecular Hepatology, 26(4), pp.652~661 (2020), 대한간학회
18. Zhao J, "The relationship between minimum alcohol prices, outlet densities and alcohol-attributable deaths in British Columbia, 2002-09", Addiction, 108, pp.1059~1069 (2013)
19. O’Donnell A, "Immediate impact of minimum unit pricing on alcohol purchases in Scotland: controlled interrupted time series analysis for 2015-18", BMJ, 366, pp.5274~ (2019)
20. Piano S, "Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide", Gastroenterology, 156, pp.1368~1380.e10 (2019)
21. Piano S, "Predictors of early readmission in patients with cirrhosis after the resolution of bacterial infections", Am J Gastroenterol, 112, pp.1575~1583 (2017)
22. Tapper EB, "Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study", BMJ, 362, pp.k2817~ (2018)
23. Piano S, "Infections complicating cirrhosis", Liver Int, 38(Supp 1), pp.126~133 (2018)

관련 논문AI추천